Sustained release micellar carrier systems for iontophoretic transport of dexamethasone across human sclera

Journal of Controlled Release

Volumn 160, Issue 1, 2012, Pages 96-104

  Chopra, Poonam ^a   Hao, Jinsong ^a   Li, S Kevin ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Dexamethasone; Human sclera; Mixed micelles; Simple micelles; Sustained release; Transscleral iontophoresis

Indexed keywords

DEXAMETHASONES; HUMAN SCLERA; MIXED MICELLES; SUSTAINED RELEASE; TRANSSCLERAL IONTOPHORESIS;

CARRIER CONCENTRATION; DRUG DELIVERY; DRUG PRODUCTS; ELECTROPHORESIS; ELECTROTHERAPEUTICS; PHOSPHOLIPIDS; SODIUM; SOLUBILITY;

MICELLES;

DEXAMETHASONE; DRUG CARRIER; PHOSPHATIDYLCHOLINE; TAUROCHOLIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ENCAPSULATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IONTOPHORESIS; MICELLE; PRIORITY JOURNAL; SCLERA; SOLUBILIZATION; SUSTAINED DRUG RELEASE;

CADAVER; CELL MEMBRANE PERMEABILITY; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DRUG CARRIERS; DRUG COMPOUNDING; FEASIBILITY STUDIES; GLUCOCORTICOIDS; HUMANS; IONTOPHORESIS; MICELLES; MODELS, BIOLOGICAL; PARTICLE SIZE; SCLERA; SOLUBILITY; SURFACE PROPERTIES;

EID: 84862826803     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.01.032     Document Type: Article

References (42)

1. N. Congdon, B. O'Colmain, C.C. Klaver, R. Klein, B. Munoz, D.S. Friedman, J. Kempen, H.R. Taylor, and P. Mitchell Causes and prevalence of visual impairment among adults in the United States Arch. Ophthalmol. 122 2004 477 485
2. S.S. Michel, A. Ekong, S. Baltatzis, and C.S. Foster Multifocal choroiditis and panuveitis - immunomodulatory therapy Ophthalmology 109 2002 378 383
3. P. Kulkarni Review: uveitis and immunosuppressive drugs J. Ocul. Pharmacol. Ther. 17 2001 181 187
4. G.J. Jaffe, J. Ben-Nun, H. Guo, J.P. Dunn, and P. Ashton Fluocinolone acetonide sustained drug delivery device to treat severe uveitis Ophthalmology 107 2000 2024 2033
5. C. Pavesio, M. Zierhut, K. Bairi, T.L. Comstock, and D.W. Usner Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis Ophthalmology 117 2010 567 575
6. I. Ahmed, R.D. Gokhale, M.V. Shah, and T.F. Patton Physicochemical determinants of drug diffusion across the conjunctiva, sclera, and cornea J. Pharm. Sci. 76 1987 583 586
7. I. Ahmed, and T.F. Patton Importance of the noncorneal absorption route in topical ophthalmic drug delivery Invest. Ophthalmol. Vis. Sci. 26 1985 584 587
8. N. Worakul, and J.R. Robinson Ocular pharmacokinetics/pharmacodynamics Eur. J. Pharm. Biopharm. 44 1997 71 83
9. D. Maurice Drug delivery to the posterior segment from drops Surv. Ophthalmol. 47 2002 S41 52
10. R.D. Jager, L.P. Aiello, S.C. Patel, and E.T. Cunningham Risks of intravitreous injection: a comprehensive review Retina 24 2004 676 698
11. J.L. Greaves, and C.G. Wilson Treatment of diseases of the eye with mucoadhesive delivery systems Adv. Drug Deliv. Rev. 11 1993 349 383
12. F. Gurtler, R. Gurny, Patent literature-review of ophthalmic inserts, Drug Dev Ind Pharm, 21 (1995) 1-18.
13. S. Gungor, M.B. Delgado-Charro, B. Ruiz-Perez, W. Schubert, P. Isom, P. Moslemy, M.A. Patane, and R.H. Guy Trans-scleral iontophoretic delivery of low molecular weight therapeutics J. Control. Release 147 2010 225 231
14. E. Eljarrat-Binstock, and A.J. Domb Iontophoresis: a non-invasive ocular drug delivery J. Control. Release 110 2006 479 489
15. S. Nicoli, G. Ferrari, M. Quarta, C. Macaluso, and P. Santi In vitro transscleral iontophoresis of high molecular weight neutral compounds Eur. J. Pharm. Sci. 36 2009 486 492
16. M.E. Myles, D.M. Neumann, and J.M. Hill Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis Adv. Drug Deliv. Rev. 57 2005 2063 2079
17. F. Behar-Cohen, A. El Aouni, S. Gautier, G. David, J. Davis, P. Chapon, and J.M. Parel Transscleral coulomb-controlled iontophoresis of methyl prednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels Exp. Eye Res. 74 2002 51 59
18. E. Eljarrat-Binstock, F. Raiskup, J. Frucht-Pery, and A.J. Domb Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel J. Control. Release 106 2005 386 390
19. F.F. Behar-Cohen, J.M. Parel, Y. Pouliquen, B. Thillaye-Goldenberg, O. Goureau, S. Heydolph, Y. Courtois, and Y. De Kozak Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats Exp. Eye Res. 65 1997 533 545
20. S.A. Molokhia, E.K. Jeong, W.I. Higuchi, and S.K. Li Examination of penetration routes and distribution of ionic permeants during and after transscleral iontophoresis with magnetic resonance imaging Int. J. Pharm. 335 2007 46 53
21. V.P. Ranta, E. Mannermaa, K. Lummepuro, A. Subrizi, A. Laukkanen, M. Antopolsky, L. Murtomaki, M. Hornof, and A. Urtti Barrier analysis of periocular drug delivery to the posterior segment J. Control. Release 148 2010 42 48
22. A. Brodin, and A. Nyqvist-Mayer In vitro release studies on lidocaine aqueous solutions, micellar solutions, and o/w emulsions Acta Pharm. Suec. 19 1982 267 284
23. S. Miyazaki, T. Yamahira, H. Inoue, and T. Nadai Interaction of drugs with bile components. II. Effect of bile on the absorption of indomethacin and phenylbutazine in rats Chem. Pharm. Bull. (Tokyo) 28 1980 323 326
24. M.F. Francis, M. Piredda, and F.M. Winnik Solubilization of poorly water soluble drugs in micelles of hydrophobically modified hydroxypropylcellulose copolymers J. Control. Release 93 2003 59 68
25. E. Hendradi, Y. Obata, K. Isowa, T. Nagai, and K. Takayama Effect of mixed micelle formulations including terpenes on the transdermal delivery of diclofenac Biol. Pharm. Bull. 26 2003 1739 1743
26. Y. Mrestani, L. Behbood, A. Härtl, and R.H.H. Neubert Microemulsion and mixed micelle for oral administration as new drug formulations for highly hydrophilic drugs Eur. J. Pharm. Biopharm. 74 2010 219 222
27. M. Sznitowska, M. Klunder, and M. Placzek Paclitaxel solubility in aqueous dispersions and mixed micellar solutions of lecithin Chem. Pharm. Bull. (Tokyo) 56 2008 70 74
28. I. Pepic, A. Hafner, J. Lovric, B. Pirkic, and J. Filipovic-Grcic A nonionic surfactant/chitosan micelle system in an innovative eye drop formulation J. Pharm. Sci. 99 2010 4317 4325
29. T. Hagigit, M. Abdulrazik, F. Valamanesh, F. Behar-Cohen, S. Benita, Ocular antisense oligonucleotide delivery by cationic nanoemulsion for improved treatment of ocular neovascularization: An in-vivo study in rats and mice, J Control Release, (in press).
30. Y.C. Tong, S.F. Chang, W.W. Kao, C.Y. Liu, and J. Liaw Polymeric micelle gene delivery of bcl-xL via eye drop reduced corneal apoptosis following epithelial debridement J. Control. Release 147 2010 76 83
31. K. Baba, Y. Tanaka, A. Kubota, H. Kasai, S. Yokokura, H. Nakanishi, and K. Nishida A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye J. Control. Release 153 2011 278 287
32. H.G. Enoch, and P. Strittmatter Formation and properties of 1000-A-diameter, single-bilayer phospholipid vesicles Proc. Natl. Acad. Sci. U. S. A. 76 1979 145 149
33. M. Ollivon, S. Lesieur, C. Grabielle-Madelmont, and M. Paternostre Vesicle reconstitution from lipid-detergent mixed micelles Biochim. Biophys. Acta 1508 2000 34 50
34. H. Naganuma, C.-L. Liu, U.K. Jain, Y. Adachi, and W.I. Higuchi Quantitative examination of the simple micelle-mixed micelle coexistence for the taurocholate-lecithin system by GP-HPLC J. Colloid Interface Sci. 189 1997 17 22
35. D.F. Kiernan, and W.F. Mieler The use of intraocular corticosteroids Expert. Opin. Pharmacother. 10 2009 2511 2525
36. P. Schurtenberger, N. Mazer, and W. Kanzig Micelle to vesicle transition in aqueous-solutions of bile-salt and lecithin J. Phys. Chem. 89 1985 1042 1049
37. M.J. Pikal The role of electroosmotic flow in transdermal iontophoresis Adv. Drug Deliv. Rev. 9 1992 201 237
38. G.B. Kasting Theoretical models for iontophoretic delivery Adv. Drug Deliv. Rev. 9 1992 177 199
39. B.A. Booth, L. Vidal Denham, S. Bouhanik, J.T. Jacob, and J.M. Hill Sustained-release ophthalmic drug delivery systems for treatment of macular disorders: present and future applications Drugs Aging 24 2007 581 602
40. C.M. Meaney, and C.M. O'Driscoll A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt:fatty acid micellar systems using the CaCo-2 cell culture model Int. J. Pharm. 207 2000 21 30
41. K. Teelmann, B. Schlappi, M. Schupbach, and A. Kistler Preclinical safety evaluation of intravenously administered mixed micelles Arzneimittelforschung 34 1984 1517 1523
42. H. Alkan-Onyuksel, S. Ramakrishnan, H.B. Chai, and J.M. Pezzuto A mixed micellar formulation suitable for the parenteral administration of taxol Pharm. Res. 11 1994 206 212